Europe Generic Injectables Market Report by Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition, Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel (Hospitals, Retail Pharmacy), and Country 2024-2032

Europe Generic Injectables Market Report by Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition, Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel (Hospitals, Retail Pharmacy), and Country 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A4032
Buy Now

Market Overview:

The Europe generic injectables market size reached US$ 20.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 41.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.77% during 2024-2032.

Report Attribute
 Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023 US$ 20.9 Billion
Market Forecast in 2032 US$ 41.8 Billion
Market Growth Rate (2024-2032) 7.77%


Generic injectables refer to alternative drugs that are equivalent to their branded counterparts in terms of the dosage, quality, strength, performance, and intended use. Generic injectables are beneficial in treating various life-threatening and chronic diseases, such as cancer, diabetes, rheumatoid arthritis, cardiovascular ailments, and respiratory infections. They aim to maximize patient compliance and reduce the frequency of administered dosage, thereby maintaining the effectiveness of the treatment.

The increasing prevalence of chronic diseases across Europe represents the key factor driving the market growth. In line with this, intravenous (IV) and intramuscular (IM) routes of drug administration are gaining widespread preference in the healthcare sector for fast drug delivery and for treating patients that are incapable of taking oral doses of medication. This is contributing to the market growth in the region significantly. Additionally, generic injectables are cost-effective as compared to branded drugs, which is acting as another growth-inducing factor. Apart from this, the increasing shortage of medicines and expiry of patents of branded items, are further creating a positive outlook for the market in Europe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the Europe generic injectables market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on therapeutic area, container, and distribution channel.

Breakup by Therapeutic Area:

  • Oncology
  • Anaesthesia
  • Anti-infectives
  • Parenteral Nutrition
  • Cardiovascular
     

Breakup by Container:

  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes
     

Breakup by Distribution Channel:

  • Hospitals
  • Retail Pharmacy
     

Breakup by Country:

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Therapeutic Area, Container, Distribution Channel, Country
Countries Covered Germany, France, United Kingdom, Italy, Spain, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The Europe generic injectables market was valued at US$ 20.9 Billion in 2023.

We expect the Europe generic injectables market to exhibit a CAGR of 7.77% during 2024-2032.

The rising prevalence of various chronic diseases, such as cancer, diabetes, osteoporosis, rheumatoid arthritis, etc., along with the increasing adoption of generic injectables, as they are cost-effective and offer enhanced patient outcomes, is primarily driving the Europe generic injectables market.

The sudden outbreak of the COVID-19 pandemic has led to the growing demand for generic injectables across several European nations, owing to the introduction of self-injection devices to reduce the risk of the coronavirus infection upon hospital visits or interaction with healthcare professionals.

Based on the therapeutic area, the Europe generic injectables market can be divided into oncology, anesthesia, anti-infectives, parenteral nutrition, and cardiovascular. Among these, oncology currently holds the majority of the total market share.

Based on the container, the Europe generic injectables market has been segmented into vials, ampoules, premix, and prefilled syringes, where vials exhibit a clear dominance in the market.

Based on the distribution channel, the Europe generic injectables market can be segregated into hospitals and retail pharmacy. Currently, hospitals account for the largest market share.

On a regional level, the market has been classified into Germany, France, United Kingdom, Italy, Spain, and others, where Germany currently dominates the Europe generic injectables market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Europe Generic Injectables Market Report by Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition, Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel (Hospitals, Retail Pharmacy), and Country 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More